Deterioration after corticosteroids in CIDP may be associated with pure focal demyelination pattern

BMC Neurology

Volumn 14, Issue 1, 2014, Pages

  Eftimov, Filip ^a   Liesdek, Marinus H ^a   Verhamme, Camillus ^a   van Schaik, Ivo N ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Chronic inflammatory demyelinating polyneuropathy; CIDP; Corticosteroids; Deterioration

Indexed keywords

DEXAMETHASONE; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; CORTICOSTEROID;

ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DEMYELINATION; ELECTROPHYSIOLOGY; FOLLOW UP; GRIP STRENGTH; HUMAN; MEDIAN NERVE; MOTOR NERVE CONDUCTION; RETROSPECTIVE STUDY; RIVERMEAD MOBILITY INDEX; SENSORY NERVE CONDUCTION; TREATMENT OUTCOME; TREATMENT RESPONSE; CONTROLLED STUDY; DISEASE COURSE; PATHOLOGY; PATHOPHYSIOLOGY; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; RANDOMIZED CONTROLLED TRIAL;

ADRENAL CORTEX HORMONES; DEXAMETHASONE; DISEASE PROGRESSION; ELECTROPHYSIOLOGY; HUMANS; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; PREDNISOLONE; TREATMENT OUTCOME;

EID: 84897957972     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-14-72     Document Type: Article

References (18)

1. Hughes R, Bensa S, Willison H, Van den BP, Comi G, Illa I, Nobile-Orazio E, van Doorn PA, Dalakas M, Bojar M, Swan A. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001, 50:195-201. 10.1002/ana.1088, 11506402.
2. van den Bergh PY, Hadden RD, Bouche P, Cornblath DR, Hahn A, Illa I, Koski CL, Leger JM, Nobile-Orazio E, Pollard J, Sommer C, van Doorn PA, van Schaik IN. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. Eur J Neurol 2010, 17:356-363. 10.1111/j.1468-1331.2009.02930.x, 20456730.
3. van Schaik IN, Eftimov F, van Doorn PA, Brusse E, Van den Berg LH, van der Pol WL, Faber CG, van Oostrom JC, Vogels OJ, Hadden RD, Kleine BU, van Norden AG, Verschuuren JJ, Dijkgraaf MG, Vermeulen M. Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial. Lancet Neurol 2010, 9:245-253. 10.1016/S1474-4422(10)70021-1, 20133204.
4. Slee M, Selvan A, Donaghy M. Multifocal motor neuropathy: the diagnostic spectrum and response to treatment. Neurology 2007, 69:1680-1687. 10.1212/01.wnl.0000277697.55288.d0, 17954783.
5. Donaghy M, Mills KR, Boniface SJ, Simmons J, Wright I, Gregson N, Jacobs J. Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry 1994, 57:778-783. 10.1136/jnnp.57.7.778, 1073014, 8021660.
6. Viala K, Renie L, Maisonobe T, Behin A, Neil J, Leger JM, Bouche P. Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome. Brain 2004, 127:2010-2017. 10.1093/brain/awh222, 15289267.
7. van Asseldonk JT, Van den Berg LH, Van Den Berg-Vos RM, Wieneke GH, Wokke JH, Franssen H. Demyelination and axonal loss in multifocal motor neuropathy: distribution and relation to weakness. Brain 2003, 126:186-198. 10.1093/brain/awg019, 12477706.
8. Busby M, Donaghy M. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients. J Neurol 2003, 250:714-724. 10.1007/s00415-003-1068-2, 12796835.
9. Kuwabara S, Misawa S, Mori M, Tamura N, Kubota M, Hattori T. Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases. J Neurol Neurosurg Psychiatry 2006, 77:66-70. 10.1136/jnnp.2005.065441, 2117396, 16361595.
10. Rajabally YA, Narasimhan M, Chavada G. Electrophysiological predictors of steroid-responsiveness in chronic inflammatory demyelinating polyneuropathy. J Neurol 2008, 255:936-938. 10.1007/s00415-008-0687-z, 18438699.
11. Sghirlanzoni A, Solari A, Ciano C, Mariotti C, Fallica E, Pareyson D. Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients. Neurol Sci 2000, 21:31-37. 10.1007/s100720070116, 10938200.
12. Franssen H, Vermeulen M, Jennekens FG. Diagnostic criteria for neuromuscular disorders. Chronic Inflammatory Neuropathies 1997, London: Royal Society Medical Press, Emery AEH.
13. Eftimov F, Vermeulen M, van Doorn PA, Brusse E, van Schaik IN. Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment. Neurology 2012, 78:1079-1084. 10.1212/WNL.0b013e31824e8f84, 22442436.
14. Nobile-Orazio E, Cocito D, Jann S, Uncini A, Beghi E, Messina P, Antonini G, Fazio R, Gallia F, Schenone A, Francia A, Pareyson D, Santoro L, Tamburin S, Macchia R, Cavaletti G, Giannini F, Sabatelli M. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. Lancet Neurol 2012, 11:493-502. 10.1016/S1474-4422(12)70093-5, 22578914.
15. Burke D, Kiernan MC, Bostock H. Excitability of human axons. Clin Neurophysiol 2001, 112:1575-1585. 10.1016/S1388-2457(01)00595-8, 11514239.
16. Park SB, Lin CS, Burke D, Kiernan MC. Activity-dependent conduction failure: molecular insights. J Peripher Nerv Syst 2011, 16:159-168. 10.1111/j.1529-8027.2011.00358.x, 22003929.
17. Nordsborg N, Goodmann C, McKenna MJ, Bangsbo J. Dexamethasone up-regulates skeletal muscle maximal Na+, K + pump activity by muscle group specific mechanisms in humans. J Physiol 2005, 567:583-589. 10.1113/jphysiol.2005.087031, 1474207, 15975987.
18. Iijima M, Yamamoto M, Hirayama M, Tanaka F, Katsuno M, Mori K, Koike H, Hattori N, Arimura K, Nakagawa M, Yoshikawa H, Hayasaka K, Onodera O, Baba M, Yasuda H, Saito T, Nakazato M, Nakashima K, Kira J, Kaji R, Oka N, Sobue G. Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP. Neurology 2005, 64:1471-1475. 10.1212/01.WNL.0000158680.89323.F8, 15851750.